Why You Cannot Sleep on Kilimanjaro

Periodic Breathing — Your Brain Fighting CO2

At sea level, your breathing is driven primarily by carbon dioxide (CO₂) levels — you breathe faster when CO₂ rises, slower when it falls. This is the vagal respiratory drive. At altitude, the equation changes: as atmospheric oxygen drops, the peripheral chemoreceptors — primarily the carotid bodies — become increasingly sensitive to even small decreases in arterial oxygen partial pressure (PaO₂).

The result is a phenomenon known as periodic breathing or Cheyne-Stokes-style respiration at altitude. The pattern unfolds over 30- to 60-second cycles: 3 to 4 deep or rapid breaths, followed by a breathing pause of 10 to 15 seconds. The pause occurs because CO₂ has built up while breathing was suppressed, and the brain temporarily inhibits respiratory drive until CO₂ crosses a threshold again. Then the cycle restarts.

Crucially, this is not obstructive sleep apnea. In obstructive apnea, the airway collapses and breathing effort increases against a closed passage. In altitude periodic breathing, the respiratory drive itself oscillates — there is no obstruction, and CPAP devices do not help and may worsen the situation by increasing CO₂ clearance and further destabilising the respiratory control loop. The pattern is most pronounced in the first 2 to 3 nights above 3,500m and tends to partially habituate by night 4 or 5 in most climbers.

Sources: Hultgren (1997), High Altitude Medicine Handbook; Nicholson et al. (2018), "Sleep at altitude," BMJ; Muhm et al. (2013), "Sleep physiology," Respiratory Physiology & Neurobiology.

Why Sleep Quality Directly Affects Acclimatization

Most climbers understand that poor sleep makes them feel terrible. Fewer understand that poor sleep also makes their bodies adapt more slowly. The link runs through a specific molecular pathway: deep NREM sleep (stage N3, slow-wave sleep) is when the majority of Hypoxia Response Element (HRE) gene activation occurs. These are the genes that drive the production of hypoxia-inducible factor (HIF-1).

HIF-1 is the master regulator of altitude adaptation. When it is upregulated, it triggers a cascade: erythropoietin (EPO) production increases, 2,3-DPG levels shift to release more oxygen from haemoglobin, and mitochondrial enzyme concentrations rise to improve cellular oxygen utilisation. This is the molecular basis of acclimatization — the process that makes the difference between a climber who reaches summit and one who turns back at 4,800m.

If sleep is severely fragmented by periodic breathing, the N3 sleep stages that trigger HIF-1 upregulation are interrupted before they complete their work. The adaptive signal is blunted. Field data from altitude research camps shows that climbers sleeping less than 4 hours on night 2 at Barranco Camp (3,900m) or Karanga (4,030m) have measurably lower SpO₂ nadirs on summit morning compared to those who slept more, controlling for age, fitness, and route.

The practical implication: altitude insomnia is not just uncomfortable. It is physiologically consequential for your summit probability. This is the scientific basis for why operators who schedule easier walking days after poor sleep nights are doing the right thing — it is not just logistical kindness, it is sound physiology. Rest days after poor sleep allow the fragmented N3 to partially recover and continue the HIF-1 driven adaptation.

The Altitude Sleep Window — When It Peaks and When It Resolves

Altitude sleep disruption follows a predictable trajectory across the climbing window:

This trajectory explains why the most strategically important nights for sleep are not the pre-summit nights — it is the nights at Barranco and Karanga on the Machame Route, and at Shira on Lemosho. Managing those nights well gives your body the best possible foundation for summit night performance.

Evidence-Based Sleep Strategies That Work on Kili

Several pharmaceutical and behavioural interventions have clinical evidence for altitude sleep management. The key distinction is between interventions that address the underlying respiratory mechanism and those that merely sedate:

Sources: Hackett (1988), "Dexamethasone for high-altitude pulmonary oedema," NEJM; Dumont (1995), "Barometric pressures and drug therapy," Wilderness Medicine; Stockmann et al. (2014), "Sleep at altitude," High Altitude Medicine & Biology; Nicholson et al. (2018), "Sleep and breathing at high altitude," BMJ.

What This Means for Your Summit Night

Summit night you will be at 5,895m. The altitude sleep disruption will be at its worst. You will have been awake for 16-18 hours and walked 12-14km. By that point, the objective is not optimizing sleep — there is no meaningful sleep available at that altitude regardless of what you do. The objective is managing fatigue across the entire climb so that summit night draws on the smallest possible deficit.

The human body is capable of remarkable performance on adrenaline and acute hypoxia for one night. That is well-documented in the altitude medicine literature. What it cannot do is compensate for accumulated sleep debt compounded by altitude physiological stress. If you have been sleeping adequately on the nights before — particularly nights 2, 3, and 4 at altitude — your body has the adaptive reserves to produce a successful summit attempt despite zero sleep at Kibo Hut.

The frame to take into summit night: accept the sleepless night as part of the protocol. It is not a failure of your preparation or a sign that you are not adapting. It is the normal, expected consequence of being at 5,895m. Your preparation is what happens on the nights before summit night.